脂质体布比卡因腹横肌平面阻滞作为非阿片类镇痛用于术后疼痛管理
本研究为单术者回顾性病历分析,纳入2010至2016年行腹腔镜袖状胃切除术(LSG)或腹腔镜胃旁路术(LRYGB)的440例患者,比较术前脂质体布比卡因腹横肌平面(TAP)阻滞联合补救阿片类药物与仅患者自控镇痛(PCA)的效果,主要结局为术后总吗啡当量。结果显示TAP组总胃肠外吗啡当量显著低于PCA组,中位住院时间由2.0天降至1.0天,但TAP LRYGB组术后即刻及12小时疼痛评分高于PCA LRYGB组。
要点
- 脂质体布比卡因TAP阻滞可显著减少减重手术术后阿片类药物用量。
- TAP阻滞组中位住院时间较PCA组缩短(1.0天 vs 2.0天)。
- LRYGB患者TAP阻滞后早期疼痛评分可能高于PCA,需关注个体化镇痛。
核心结论
- 脂质体布比卡因TAP阻滞较单纯PCA显著减少胃肠外吗啡当量用量并缩短住院时间。
- TAP LRYGB组术后即刻及12小时疼痛评分显著高于PCA LRYGB组。
- LSG组中TAP与PCA的疼痛评分无差异。
研究设计与样本
- 单术者、经IRB批准的回顾性病历分析。
- 纳入2010至2016年连续行LRYGB或LSG的患者440例。
- 按术前接受TAP阻滞联合补救阿片类药物(TAP组)或仅PCA(PCA组)分组。
主要发现
- TAP组总胃肠外吗啡当量显著低于PCA组:LRYGB为26.5 ± 1.5 vs 70.4 ± 2.7(p ≤ 0.0001),LSG为24.1 ± 2.0 vs 60.0 ± 3.5(p < 0.0001)。
- 中位住院时间PCA组均为2.0天,TAP组均降至1.0天(p < 0.0001)。
- TAP LRYGB组术后即刻及12小时疼痛评分显著高于PCA LRYGB组(p < 0.05)。
- LSG组术后即刻疼痛评分PCA vs TAP阻滞比较p = 0.0109。
临床怎么用
- 可考虑将脂质体布比卡因TAP阻滞作为减重手术多模式镇痛的一部分以减少阿片类药物用量。
- 对LRYGB患者实施TAP阻滞时需注意早期疼痛评分可能较高,应结合其他镇痛措施。
局限性
- 回顾性单术者设计可能限制普遍性。
- 原文未报告30天再入院率的具体数值。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: The use of non-narcotic modalities for postoperative analgesia may decrease exposure to opioids, thereby limiting their deleterious effects. The objective of this study was to determine the effectiveness of a liposomal bupivacaine transverse abdominis plane (TAP) block prior to laparoscopic sleeve gastrectomy (LSG) and laparoscopic gastric bypass (LRYGB). The primary outcome was total postoperative morphine equivalents. METHODS: A single-surgeon, IRB-approved retrospective chart review was performed on consecutive patients who underwent LRYGB or LSG from 2010 to 2016. Patients were grouped according to those who received TAP blocks immediately preoperatively with rescue opioids (TAP group) and those who received PCA only (PCA group). Total parenteral morphine equivalents (PME) were calculated. Numerical pain scores were collected immediately following surgery, 12 h postoperatively, and on the day of discharge. Median length of stay (LOS) and 30-day readmissions were also calculated. RESULTS: There were 440 patients who met inclusion criteria. The TAP group had significantly less opioid use (total PME) than the PCA, irrespective of surgical approach (70.4 ± 2.7 PCA LRYGB and 26.5 ± 1.5 TAP block LRYGB, p value ≤ 0.0001; 60.0 ± 3.5 PCA LSG vs. and 24.1 ± 2.0 TAP block LSG, p value < 0.0001). Median LOS was 2.0 days for both PCA groups, whereas LOS decreased to 1.0 day for both groups of patients receiving TAP blocks (p < 0.0001). Pain scores immediately following and 12 h after surgery were significantly elevated in the TAP LRYGB versus PCA LRYGB (p < 0.05) and immediately following surgery for PCA versus TAP block for LSG (p = 0.0109). CONCLUSIONS: TAP blocks with liposomal bupivacaine lead to significantly less use of parenteral morphine equivalents and decreased LOS compared to PCA alone. Pain scores were higher in the TAP LRYGB group compared to the LRYGB PCA group, with no differences in pain scores noted in the LSG groups.
引用
- Robertson TC, Hall K, Bear S, et al. Transversus abdominis block utilizing liposomal bupivacaine as a non-opioid analgesic for postoperative pain management. Surg Endosc. 2018. PMID: 30390161. doi:10.1007/s00464-018-6543-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。